<DOC>
	<DOCNO>NCT01455610</DOCNO>
	<brief_summary>The purpose multicenter double-blind clinical trial prospectively assess sensitivity , specificity , negative predictive value , positive predictive value , accuracy respectability pancreatic head cancer contrasted-enhanced MDCT various post processing technique , take operational pathological record gold standard .</brief_summary>
	<brief_title>Resectability Pancreatic Head Cancer Contrast-enhanced MDCT : Multi-center Study</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>Patients ( suspect ) pancreatic head cancer Being examine contrastedenhanced MDCT Receiving surgical treatment ( include palliative surgery ) research center Patients ( suspect ) pregnancy breastfeed Patients allergic reaction iodinate contrast agent Hypersensitivity reaction allergen ( include drug ) Patients receive ERCP contrastedenhanced MDCT examination Patients without surgery high degree surgical risk</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Computed tomography</keyword>
	<keyword>Contrast enhancement</keyword>
	<keyword>Pancreas</keyword>
	<keyword>Cancer</keyword>
	<keyword>Resectability</keyword>
</DOC>